"Revolutionary" new prostate cancer treatment - ABC 12 – WJRT – Flint, MI

"Revolutionary" new prostate cancer treatment

Posted: Updated:
FLINT (WJRT) -

(02/06/13) - There is a new way to attack prostate cancer - an innovative therapy that can be used instead of surgery and radiation for patients with early stage cancers that may have spread.

When Charles King found out he had prostate cancer, he knew one thing, "at that point, I had a decision to make. What was I going to do about it?"

Charles enrolled in a clinical trial that could revolutionize the way prostate cancer is treated.

Dr. Mark Buyyounouski agrees. "This is big stuff. This is very big."

Buyyounouski says traditional therapies don't address the risk of the cancer spreading throughout the body. "We know like weeds in a garden if there are one or two cells that have escaped, they could come back years from now."

That's where Prostatak comes in. The vaccine therapy is injected into the prostate, where it infects cancer cells and, together with radiation, stimulates the patient's own immune system to rid the body of cancer.
 
"It's an entirely different way to treat prostate cancer," Buyyounouski says.

Preliminary study results show Prostatak is safe and effective in killing prostate cancer, dropping tumor recurrence from 30 percent to less than 10 percent.

Charles hopes it works for him. In the meantime, he's focusing on what's important. "Play with those grand kids, I mean, they're our, they're our world and our life."     

Prostatak is designed for men in the early stages of prostate cancer. It is ideal for patients with intermediate or high risk prostate cancer who are considering radiation therapy. Trials are going on right now. for more information about how to participate, call 215-728-5312.

Powered by WorldNow

abc12.com

ABC12 Main Station
810-233-3130

Mailing Address:
2302 Lapeer Road
Flint, Michigan 48503

Powered by 

WorldNow
All content © Copyright 2000 - 2014 WorldNow and WJRT. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.